Rationale, Design, and Baseline Clinical Characteristics of the Ziltivekimab Cardiovascular Outcomes Trial

Post time 14 hour(s) ago

journal：JAMA Cardiology

Authors：Paul M Ridker; Florian M. M. Baeres; Anders Hvelplund; Mads M. D. Engelmann; G. Kees Hovingh; A. Michael Lincoff; Nikolaus Marx; Ann Marie Navar; Naveed Sattar; Katherine Tuttle; Vlado Perkovic

Published date：2026-1-1

DOI：10.1001/jamacardio.2025.4491

PDF link：https://jamanetwork.com/journals ... 776953463.57247.pdf

Article link：https://doi.org/10.1001/jamacardio.2025.4491

Article Source：American Medical Association (AMA)。

Remark：

Post time Half hour(s) ago

: Waiting for confirmation
If the PDF has not been accepted after 72 hours, the system will automatically adopt it.

[JAMA] Rationale, Design, and Baseline Clinical Characteristics of the Ziltivekimab Cardiovascular Outcomes Trial

Same Category

Latest Reply

Announcement

Daily Top Contributors

[JAMA] Rationale, Design, and Baseline Clinical Characteristics of the Ziltivekimab Cardiovascular Outcomes Trial Copy

Same Category

Latest Reply

Announcement

Daily Top Contributors

[JAMA] Rationale, Design, and Baseline Clinical Characteristics of the Ziltivekimab Cardiovascular Outcomes Trial